Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX ยท Real-Time Price ยท USD
1.390
-0.130 (-8.55%)
At close: Nov 18, 2026, 4:00 PM EST
1.453
+0.063 (4.55%)
After-hours: Nov 18, 2026, 7:37 PM EST
Medicus Pharma Earnings Call Transcripts
Fiscal Year 2026
-
Nine-month losses widened as investment supported the Pfizer CD228V license, while Q3 expenses and net loss declined YoY. Priorities are CD228V development, a proposed SkinJect SPAC transaction, and Teverelix partnerships.